Avatar for DeckTherapeutics

An Omega 3 lipid emulsion that can prevent paralysis, and death after stroke

An Omega 3 lipid emulsion that can prevent paralysis, and death after stroke

Using existing fatty acids through novel compounds Dr. Deckelbaum and his lab have created a novel omega 3 emulsion. When acutely administered after a hypoxic-ischemic injury due to stroke there is markedly enhanced tissue and organ survival with associated functional recovery. A major underserved market for this product will be stroke. The acute administration approach is in contrast to long term supplements with omega 3 fatty acids before symptoms of a traumatic event. Injury related damage (to cells, tissues, and organs) is reduced by up to 90% in 6 different rodent models. Acute injection of omega 3 glycerides not only significantly increases tissue survival but also preserves short and long term organ functional outcomes.

DeckTherapeutics hasn't added any jobs yet

Get notified when DeckTherapeutics posts new jobs.

See similar jobs